Sign in

CIK 0000812796

  • Non-accelerated filer
  • Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411505029
Phone
+1 609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2009-09-24 SIGMA TAU FINANZIARIA SPA 10% owner Purchase +3,952,569 $0.25 $1000K 45,619,236
2009-09-24 SIGMA TAU FINANZIARIA SPA 10% owner Other acquisition · Common Stock Warrant (right to buy) +1 1
2009-09-24 CAVAZZA PAOLO 10% owner Purchase +3,952,569 $0.25 $1000K 45,619,236
2009-09-24 CAVAZZA PAOLO 10% owner Other acquisition · Common Stock Warrant (warrant to buy) +1 1
2009-09-24 CAVAZZA CLAUDIO 10% owner Purchase +3,952,569 $0.25 $1000K 45,619,236
2009-09-24 CAVAZZA CLAUDIO 10% owner Other acquisition · Common Stock Warrant (warrant to buy) +1 1
2009-09-18 Biotex Pharma Investments, LLC 10% owner Returned to the company −250,000 $0.27 $66K 18,750,000
2009-08-11 Biotex Pharma Investments, LLC 10% owner Sale −500,000 $0.20 $100K 19,000,000
2009-07-30 Biotex Pharma Investments, LLC 10% owner Sale −500,000 $0.20 $102K 19,500,000
2009-07-01 SCHNITTKER CHRISTOPHER P VP ADMIN CONTROLLER Grant or award · Stock Option (Right to Buy) +750,000 750,000
2009-06-04 Buhrman Cyrille F Director Grant or award · Stock Options (right to buy) +250,000 250,000
2009-06-04 Lapointe Gregg Anthony Director Grant or award · Stock Options (right to buy) +37,500 37,500
2009-06-04 KUO JAMES S Director Grant or award · Stock Option (right to buy) +250,000 250,000
2009-03-11 Hamilton Brian L Chief Medical Officer Grant or award · Stock Options (right to buy) +1,000,000 1,000,000
2009-03-10 Lapointe Gregg Anthony Director Grant or award · Stock Options (right to buy) +300,000 300,000
2009-02-11 SIGMA TAU FINANZIARIA SPA 10% owner Purchase +25,000,000 $0.18 $4.5M 41,666,667
2009-02-11 CAVAZZA PAOLO 10% owner Purchase +25,000,000 $0.18 $4.5M 41,666,667
2009-02-11 CAVAZZA CLAUDIO 10% owner Purchase +25,000,000 $0.18 $4.5M 41,666,667
2008-12-18 Brey Robert N Chief Scientific Officer/SrVP Grant or award · Stock Options (Right to Buy) +800,000 800,000
2008-12-18 SCHABER CHRISTOPHER J Chief Executive Officer Grant or award · Stock Option (Right to Buy) +2,800,000 2,800,000

Page 16 of 22 · 422 trades